USPTO serial 79355008
XKEN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 18, 2025
- Examiner
- GARTNER, JOHN M
- Law office
- TMO LAW OFFICE 119
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with XKEN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Mosaiques Diagnostics and Therapeutics AG
DE
Other trademarks owned by Mosaiques Diagnostics and Therapeutics AG
Mosaiques Diagnostics and Therapeutics AG
DE
Other trademarks owned by Mosaiques Diagnostics and Therapeutics AG
Mosaiques Diagnostics and Therapeutics AG
DE
Other trademarks owned by Mosaiques Diagnostics and Therapeutics AG
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biochemical preparations for scientific purposes; diagnostic preparations for clinical use; diagnostic reagents and preparations, except for medical or veterinary use; diagnostic reagents sold as a set, except for medical or veterinary use; chemical diagnostic reagents, except for medical or veterinary use; diagnostic reagents for in vitro applications, except for medical or veterinary use; diagnostic preparations, other than for medical or veterinary purposes; diagnostic preparations for scientific purposes; chemical preparations for scientific and biological uses, other than for medical or veterinary use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology, except for medical or veterinary use | ACTIVE | — |
| 005 | Chemical diagnostic reagents for medical purposes; diagnostic agents for medical purposes; diagnostic agents for veterinary purposes; reagents for clinical medical diagnostics; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; in vitro diagnostic preparations for medical purposes; medical and veterinary diagnostic reagents for testing of body fluids; chemical reagents for medical or veterinary purposes; biochemical preparations for use in the treatment of cardiovascular diseases and inflammatory diseases and in the fields of nephrology, oncology, and transplantation; biological diagnostic reagents for medical purposes | ACTIVE | — |
| 042 | Medical and pharmaceutical research services; scientific and technological services, namely, scientific research, analysis, and testing in the field of clinical diagnosis; biomedical research; clinical research in the fields of cardiovascular diseases, inflammatory diseases, nephrology, oncology, and transplantation; medical laboratory services; research and development services in the field of diagnostic agents; product design and development in the field of medical technology; consulting related to pharmacology; conducting biotechnological tests, namely, testing, analysis, and evaluation of urine for scientific research purposes; computer software development in the field of data processing for medical, pharmaceutical and biotechnological applications; natural science services, namely, research services in the field of the general health of humans | ACTIVE | — |
| 044 | Medical services; healthcare; medical testing for diagnostic or treatment purposes; medical diagnosis of cardiovascular diseases, inflammatory diseases, and in the fields of nephrology, oncology, and transplantation; medical analysis for the diagnosis and treatment of persons; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical testing for diagnostic or treatment purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Mosaiques Diagnostics and Therapeutics AG
- Other trademarks owned by Mosaiques Diagnostics and Therapeutics AG
- Other trademarks owned by Mosaiques Diagnostics and Therapeutics AG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named XKEN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 3, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 3, 2026 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Sep 3, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 3, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 19, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 31, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 31, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 18, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 18, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Feb 18, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 31, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 31, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 25, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 22, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 21, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 21, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 21, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jun 4, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 4, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jun 4, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 4, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 29, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 29, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 29, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 29, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 10, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 10, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Apr 1, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 1, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 1, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 1, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 1, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Dec 6, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 6, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 6, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 26, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 9, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 8, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 8, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 28, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 22, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 21, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 18, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 18, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 14, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 10, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |